Seeking Alpha

"The (pharmaceutical) industry needs to spend more money on R&D and less on sales and...

"The (pharmaceutical) industry needs to spend more money on R&D and less on sales and marketing, says Novartis (NVS +1.2%) CEO Joseph Jimenez. He also believes "that in the future, companies like Novartis are going to be paid on patient outcomes as opposed to selling the pill." However, Jimenez warns that price cuts, such as those in Europe, "create a disincentive for us to build sales force."
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs